Swiss All Share Index
18.164,82
PKT
+460,10
PKT
+2,60
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.03.15 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.03.15 | Holcim Sell | S&P Capital IQ | |
| 16.03.15 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 13.03.15 | Holcim Neutral | UBS AG | |
| 13.03.15 | UBS Hold | Commerzbank AG | |
| 12.03.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 11.03.15 | UBS neutral | Morgan Stanley | |
| 11.03.15 | UBS buy | Goldman Sachs Group Inc. | |
| 11.03.15 | UBS overweight | JP Morgan Chase & Co. | |
| 11.03.15 | UBS Neutral | UBS AG | |
| 09.03.15 | Nestlé Reduce | Nomura | |
| 04.03.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.15 | Roche Outperform | BNP PARIBAS | |
| 04.03.15 | Novartis Outperform | BNP PARIBAS | |
| 03.03.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.03.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.03.15 | Novartis buy | UBS AG | |
| 02.03.15 | UBS Underperform | BNP PARIBAS | |
| 02.03.15 | UBS buy | Goldman Sachs Group Inc. | |
| 02.03.15 | UBS buy | Goldman Sachs Group Inc. | |
| 02.03.15 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 27.02.15 | UBS Outperform | BMO Capital Markets | |
| 27.02.15 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 27.02.15 | Swiss Re Hold | Société Générale Group S.A. (SG) | |
| 26.02.15 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.02.15 | UBS Underperform | BNP PARIBAS | |
| 26.02.15 | UBS Underperform | BNP PARIBAS | |
| 24.02.15 | Holcim buy | S&P Capital IQ | |
| 24.02.15 | Holcim buy | Jefferies & Company Inc. | |
| 24.02.15 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 24.02.15 | Holcim buy | Deutsche Bank AG | |
| 24.02.15 | Holcim buy | Deutsche Bank AG | |
| 23.02.15 | Nestlé Halten | Independent Research GmbH | |
| 23.02.15 | BB Biotech Verkaufen | Independent Research GmbH | |
| 23.02.15 | Zurich Insurance Kauf | Independent Research GmbH | |
| 23.02.15 | Givaudan buy | UBS AG | |
| 23.02.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 23.02.15 | Roche Neutral | UBS AG | |
| 23.02.15 | Swiss Re add | Commerzbank AG |